Commodore Capital LP 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-11 5:15 pm Purchase |
2025-04-04 | 13G | Viridian Therapeutics, Inc. VRDN |
Commodore Capital LP | 4,300,000 5.300% |
2,375,926 (+123.48%) |
Filing |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Commodore Capital LP | 1,924,074 3.700% |
552,735 (+40.31%) |
Filing |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Commodore Capital LP | 2,020,166 5.000% |
2,020,166 (New Position) |
Filing |
| 2022-05-19 4:30 pm Purchase |
2022-05-09 | 13G | Viridian Therapeutics, Inc. VRDN |
Commodore Capital LP | 1,371,339 5.000% |
1,371,339 (New Position) |
Filing |